Cutting edge: TCR stimulation is sufficient for induction of Foxp3 expression in the absence of DNA methyltransferase 1.

TitleCutting edge: TCR stimulation is sufficient for induction of Foxp3 expression in the absence of DNA methyltransferase 1.
Publication TypeJournal Article
Year of Publication2009
AuthorsJosefowicz SZ, Wilson CB, Rudensky AY
JournalJ Immunol
Volume182
Issue11
Pagination6648-52
Date Published2009 Jun 01
ISSN1550-6606
KeywordsAnimals, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, DNA (Cytosine-5-)-Methyltransferase 1, DNA (Cytosine-5-)-Methyltransferases, Forkhead Transcription Factors, Lymphocyte Count, Mice, Mice, Knockout, Receptors, Antigen, T-Cell, Transcriptional Activation, Transforming Growth Factor beta1
Abstract

TCR signaling is important for regulatory T cell (Tr) development. Using a genetic model of DNA methyltransferase 1 (Dnmt1) deficiency, we observed highly efficient Foxp3 induction following TCR stimulation, suggesting a dominant role for TCR signaling in Foxp3 induction. In the absence of Dnmt1, Foxp3 induction in thymic and peripheral Foxp3-negative T cells was maximized upon TCR engagement, and the provision of TGF-beta was dispensable for Foxp3 expression. In addition, CD4-Cre x dnmt1(fl/fl) mice harbored sizeable thymic and peripheral populations of CD8(+)Foxp3(+) cells, suggesting that Dnmt1 activity is required for restricting Foxp3 expression to the CD4 T cell lineage. Our results suggest that the TCR signal is sufficient for transcriptional activation of Foxp3 in the absence of maintenance DNA methylation and that TGF-beta facilitates Foxp3 induction in part by opposing cell cycle-dependent Dnmt1 recruitment, leading to locus inactivation.

DOI10.4049/jimmunol.0803320
Alternate JournalJ Immunol
PubMed ID19454658
Grant ListR01 AI034206 / AI / NIAID NIH HHS / United States
/ HHMI / Howard Hughes Medical Institute / United States
Related Faculty: 
Steven Josefowicz, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700